Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Churg-Strauss Syndrome | 3 | 2025 | 27 | 2.450 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2 | 2024 | 24 | 1.620 |
Why?
|
| Granulomatosis with Polyangiitis | 2 | 2023 | 47 | 1.550 |
Why?
|
| Down Syndrome | 3 | 2026 | 534 | 1.430 |
Why?
|
| Submandibular Gland | 1 | 2025 | 20 | 0.900 |
Why?
|
| Interleukin-5 | 1 | 2025 | 39 | 0.890 |
Why?
|
| Rheumatic Diseases | 1 | 2026 | 97 | 0.880 |
Why?
|
| Microscopic Polyangiitis | 1 | 2023 | 13 | 0.810 |
Why?
|
| Granuloma | 2 | 2023 | 96 | 0.790 |
Why?
|
| Myositis | 1 | 2023 | 57 | 0.750 |
Why?
|
| Antibodies, Monoclonal, Humanized | 3 | 2025 | 988 | 0.690 |
Why?
|
| Sarcoidosis | 1 | 2023 | 160 | 0.670 |
Why?
|
| Hemorrhage | 2 | 2023 | 809 | 0.610 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 3 | 2024 | 33 | 0.610 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 383 | 0.570 |
Why?
|
| Histiocytosis | 1 | 2017 | 9 | 0.540 |
Why?
|
| Contracture | 1 | 2017 | 23 | 0.530 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2017 | 73 | 0.500 |
Why?
|
| Lung Diseases | 1 | 2021 | 787 | 0.420 |
Why?
|
| Glucocorticoids | 3 | 2025 | 535 | 0.410 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 741 | 0.350 |
Why?
|
| Child | 8 | 2026 | 22657 | 0.330 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 1495 | 0.200 |
Why?
|
| Humans | 12 | 2026 | 144957 | 0.200 |
Why?
|
| Fasciitis | 1 | 2023 | 11 | 0.200 |
Why?
|
| Rheumatology | 1 | 2024 | 133 | 0.190 |
Why?
|
| Needs Assessment | 1 | 2024 | 404 | 0.170 |
Why?
|
| Fibrosis | 1 | 2023 | 548 | 0.160 |
Why?
|
| Vasculitis | 1 | 2021 | 69 | 0.160 |
Why?
|
| Ultrasonography | 1 | 2024 | 770 | 0.160 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 357 | 0.160 |
Why?
|
| Lower Extremity | 1 | 2023 | 438 | 0.140 |
Why?
|
| Immunosuppressive Agents | 1 | 2023 | 847 | 0.140 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2021 | 252 | 0.140 |
Why?
|
| Infliximab | 1 | 2018 | 108 | 0.140 |
Why?
|
| Male | 6 | 2025 | 72406 | 0.140 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2017 | 8 | 0.140 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2018 | 126 | 0.130 |
Why?
|
| Azathioprine | 1 | 2017 | 49 | 0.130 |
Why?
|
| Infant | 2 | 2025 | 10039 | 0.130 |
Why?
|
| Pain | 1 | 2023 | 782 | 0.130 |
Why?
|
| Female | 6 | 2024 | 78376 | 0.130 |
Why?
|
| Altitude | 1 | 2021 | 473 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2025 | 11695 | 0.120 |
Why?
|
| Prednisone | 1 | 2017 | 221 | 0.120 |
Why?
|
| Hospitals | 1 | 2021 | 732 | 0.120 |
Why?
|
| Coronary Vessels | 1 | 2018 | 251 | 0.120 |
Why?
|
| Methotrexate | 1 | 2017 | 240 | 0.120 |
Why?
|
| Logistic Models | 1 | 2021 | 2119 | 0.120 |
Why?
|
| Antirheumatic Agents | 1 | 2018 | 304 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 338 | 0.110 |
Why?
|
| Echocardiography | 1 | 2018 | 652 | 0.110 |
Why?
|
| Aspirin | 1 | 2018 | 400 | 0.110 |
Why?
|
| Child, Preschool | 2 | 2021 | 11799 | 0.100 |
Why?
|
| Skin | 1 | 2018 | 758 | 0.100 |
Why?
|
| United States | 2 | 2021 | 15988 | 0.090 |
Why?
|
| Inflammation | 1 | 2023 | 2880 | 0.090 |
Why?
|
| Biomarkers | 1 | 2023 | 4275 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2023 | 7997 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2021 | 6434 | 0.080 |
Why?
|
| Asthma | 1 | 2021 | 1768 | 0.070 |
Why?
|
| Pregnancy | 1 | 2021 | 7191 | 0.070 |
Why?
|
| Young Adult | 1 | 2023 | 14126 | 0.060 |
Why?
|
| Adolescent | 1 | 2025 | 22453 | 0.060 |
Why?
|
| Aged | 1 | 2023 | 25947 | 0.050 |
Why?
|
| North America | 1 | 2024 | 310 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2021 | 17101 | 0.050 |
Why?
|
| Middle Aged | 1 | 2023 | 35928 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 557 | 0.040 |
Why?
|
| Adult | 2 | 2024 | 40506 | 0.040 |
Why?
|
| Eosinophils | 1 | 2021 | 316 | 0.030 |
Why?
|
| Curriculum | 1 | 2024 | 1060 | 0.030 |
Why?
|
| Pediatrics | 1 | 2024 | 1115 | 0.030 |
Why?
|